SANJIVIN
Sanjivani Paranteral Ltd
Pharmaceuticals · ₹176 Cr market cap
A research-based pharmaceutical company engaged in the development and manufacturing of parenteral formulations and injectable medicines. Established in 1994, the company serves both domestic and international markets across multiple therapeutic areas including oncology, cardiology, infectious diseases, and critical care. Its export-oriented business model distinguishes it as a significant player in the global pharmaceutical supply chain, maintaining compliance with stringent international regulatory and quality standards.
1
Tracked investors holding
0
Tracked moves
₹144
Share price
Top investors holding Sanjivani Paranteral Ltd
3.01%
Track smart money in Sanjivani Paranteral Ltd
Get alerted when a top investor buys or sells.
Get started